Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sanders, R. D.
Right arrow Articles by Maze, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders, R. D.
Right arrow Articles by Maze, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2003, Vol. 91, No. 5 709-717
© 2003 The Board of Management and Trustees of the British Journal of Anaesthesia

Xenon: no stranger to anaesthesia

R. D. Sanders1,3, N. P. Franks1,2 and M. Maze1,2,3

1 Department of Anaesthetics and Intensive Care, Faculty of Medicine, and 2 Biophysics Section, Department of Biological Sciences, Imperial College London, UK. 3 Magill Department of Anaesthesia, Intensive Care and Pain Management, Chelsea and Westminster Hospital, Chelsea and Westminster Healthcare NHS Trust, London, UK

Corresponding author. E-mail: m.maze@ic.ac.uk
{dagger}Declaration of interest. Professor Maze and Professor Franks are Board members of an Imperial College spin-out company (Protexeon Ltd) that is interested in developing clinical applications for medical gases, including xenon. Both Professor Franks and Professor Maze are paid consultants in this activity. In addition, Air Products have funded, and continue to fund, work in the authors’ laboratories that bears on the actions of xenon as an anaesthetic and neuroprotectant, and Air Products has a financial stake in Protexeon Ltd.

Abstract

Br J Anaesth 2003; 91: 709–17


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
A. R. Barakat, M. N. Schreiber, J. Flaschar, M. Georgieff, and S. Schraag
The Effective Concentration 50 (EC50) for Propofol with 70% Xenon Versus 70% Nitrous Oxide
Anesth. Analg., March 1, 2008; 106(3): 823 - 829.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
E. J. Bertaccini, J. R. Trudell, and N. P. Franks
The Common Chemical Motifs Within Anesthetic Binding Sites
Anesth. Analg., February 1, 2007; 104(2): 318 - 324.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Sakamoto, S. Nakao, M. Masuzawa, T. Inada, M. Maze, N. P. Franks, and K. Shingu
The Differential Effects of Nitrous Oxide and Xenon on Extracellular Dopamine Levels in the Rat Nucleus Accumbens: A Microdialysis Study
Anesth. Analg., December 1, 2006; 103(6): 1459 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
I. L. White, N. P. Franks, and R. Dickinson
Effects of isoflurane and xenon on Ba2+-currents mediated by N-type calcium channels
Br. J. Anaesth., June 1, 2005; 94(6): 784 - 790.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. Dinse, K. J. Fohr, M. Georgieff, C. Beyer, A. Bulling, and H. U. Weigt
Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones
Br. J. Anaesth., April 1, 2005; 94(4): 479 - 485.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
B. Preckel and W. Schlack
Editorial III: Xenon--cardiovascularly inert?
Br. J. Anaesth., June 1, 2004; 92(6): 786 - 789.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.